ADRA2A and type 2 diabetes mellitus: In order to explore the mechanisms of the lessened therapeutic effect of T2D ASCs, we compared the transcriptomic profiles of T2D and normal ASCs and found that the expression of α2A-adrenergic receptor (Adra2a) was significantly increased in T2D ASCs.